BioCentury
ARTICLE | Clinical News

Ozurdex dexamethasone intravitreal implant regulatory update

September 15, 2014 7:00 AM UTC

Allergan said the European Commission expanded the label of Ozurdex dexamethasone intravitreal implant to include treatment of visual impairment due to diabetic macular edema (DME) in adults who are p...